The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty

Cornea

Volumn 24, Issue 7, 2005, Pages 833-836

  Moshirfar, Majid ^a   Marx, Douglas P ^a   Kumar, Rajiv ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic; Cornea; Fluoroquinolones; Keratoplasty

Indexed keywords

EYE OINTMENT; GATIFLOXACIN; HYPOTEARS; MAXITROL; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REFRESH PLUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA TRANSPLANTATION; DRUG EFFECT; EPITHELIZATION; FEMALE; HUMAN; MALE; OUTCOMES RESEARCH; PENETRATING KERATOPLASTY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SLIT LAMP;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CHILD; EPITHELIUM, CORNEAL; EYE INFECTIONS, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUINOLINES; WOUND HEALING;

EID: 25844461293     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000157420.11448.d4     Document Type: Article

References (7)

1. Pollock GA, McKelvie PA, McCarty DJ, et al. in vivo effects of fluoroquinolones on rabbit corneas. Clin Exp Ophthalmol. 2003;31:517-521.
2. Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv Ther. 2001;18:205-215.
3. Paugh JR, Sasai A, Joshi A. Preservative effect on epithelial barrier function measured with a novel technique. Adv Exp Med Biol. 1998;438:731-735.
4. Moller-Pedersen T, Cavanaugh HD, Petroli WM, et al. Stromal wound healing explains refractive instability and haze development after photorefractive keratectomy: a 1-year confocal microscopic study. Ophthalmology. 2000;107:1235-1246.
5. Jensen HG, Felix C. in vitro antibiotic susceptibilities of ocular isolates in North and South America. Cornea. 1998;17:79-87.
6. Callegan MC, Ramirez R, Kane ST, et al. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther. 2003;20:246-252.
7. Kowalski RP, Dhaliwal DK, Karenchak LM, et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 2003;136:500-505.